Emmanuel Chigutsa Selected Research

Emmanuel Chigutsa Research Topics

6	Tuberculosis (Tuberculoses) 11/2018 - 09/2011
4	COVID-19 01/2022 - 11/2021
3	Hypoglycemia (Reactive Hypoglycemia) 05/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2023
1	Amyloid Plaque 04/2023
1	Disease Progression 04/2023
1	Alzheimer Disease (Alzheimer's Disease) 04/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Infections 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Acute Coronary Syndrome 01/2018
1	Neoplasms (Cancer) 01/2017
1	Pulmonary Tuberculosis 01/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2008

3	Insulin (Novolin)FDA Link 01/2023 - 01/2023
3	Monoclonal AntibodiesIBA 01/2022 - 11/2018
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 09/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2023
2	insulin degludecIBA 01/2023 - 01/2023
2	bamlanivimabIBA 01/2022 - 12/2021
2	bamlanivimab and etesevimab drug combinationIBA 01/2022 - 11/2021
2	Moxifloxacin (Avelox)FDA Link 11/2018 - 01/2014
2	Pyrazinamide FDA LinkGeneric 01/2015 - 09/2011
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2015 - 09/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2015 - 09/2011
1	Glucagon (Glukagon)FDA Link 05/2023
1	donanemabIBA 04/2023
1	Amyloid (Amyloid Fibrils)IBA 04/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	abemaciclibIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2018
1	ixekizumabIBA 11/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	Purinergic P2Y Receptor AntagonistsIBA 01/2018
1	Prasugrel Hydrochloride FDA Link 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	LigandsIBA 01/2017
1	necitumumabIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 07/2012
1	FluoroquinolonesIBA 07/2012
1	efavirenz (Sustiva)FDA Link 04/2008
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 04/2008